HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manabu Fujimoto Selected Research

Arthus Reaction

9/2012Basophils and mast cells play critical roles for leukocyte recruitment in IgE-mediated cutaneous reverse passive Arthus reaction.
1/2010Platelets control leukocyte recruitment in a murine model of cutaneous arthus reaction.
6/2009Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction.
5/2007Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 cooperatively contribute to the cutaneous Arthus reaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manabu Fujimoto Research Topics

Disease

59Systemic Scleroderma (Systemic Sclerosis)
11/2022 - 06/2002
41Dermatomyositis (Dermatopolymyositis)
07/2022 - 04/2003
33Neoplasms (Cancer)
07/2022 - 04/2011
29Fibrosis (Cirrhosis)
01/2020 - 06/2002
27Melanoma (Melanoma, Malignant)
08/2022 - 11/2011
23Myositis (Idiopathic Inflammatory Myopathies)
04/2022 - 02/2012
15Inflammation (Inflammations)
01/2022 - 09/2004
13Interstitial Lung Diseases (Interstitial Lung Disease)
04/2018 - 01/2010
12Autoimmune Diseases (Autoimmune Disease)
01/2022 - 03/2007
12Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2011 - 09/2006
11Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 04/2003
10Psoriasis (Pustulosis Palmaris et Plantaris)
12/2022 - 01/2008
9Sclerosis
05/2019 - 06/2002
8Dermatitis
12/2022 - 09/2004
7Neoplasm Metastasis (Metastasis)
01/2018 - 11/2011
6Contact Dermatitis (Eczema, Contact)
01/2022 - 05/2007
6Rheumatoid Arthritis
01/2022 - 11/2010
6Hemorrhage
01/2021 - 05/2007
6Disease Progression
05/2019 - 10/2008
5Necrosis
01/2022 - 04/2006
5Polymyositis
12/2021 - 01/2010
5Vitiligo
09/2020 - 02/2017
5Wounds and Injuries (Trauma)
11/2015 - 09/2007
4Localized Scleroderma (Morphea)
11/2022 - 01/2003
4Bullous Pemphigoid (Pemphigoid)
02/2022 - 05/2007
4Amyopathic dermatomyositis
12/2021 - 04/2013
4Arthritis (Polyarthritis)
01/2019 - 01/2009
4Bronchiolitis Obliterans Syndrome
04/2017 - 12/2012
4Connective Tissue Diseases (Connective Tissue Disease)
01/2017 - 12/2007
4Arthus Reaction
09/2012 - 05/2007
3Atopic Dermatitis (Atopic Eczema)
01/2022 - 05/2007
3Alopecia Areata
01/2022 - 03/2007
3Calcinosis
01/2022 - 04/2013
3Erythema
10/2021 - 03/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021 - 07/2017
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 05/2007
3Skin Manifestations
08/2020 - 10/2004
3Hemangiosarcoma (Angiosarcoma)
11/2019 - 06/2018
3Hypersensitivity (Allergy)
09/2019 - 05/2007
3Edema (Dropsy)
07/2019 - 05/2007
3Vasculitis (Vasculitides)
01/2019 - 06/2009
3Fever (Fevers)
01/2019 - 04/2013
3Extramammary Paget Disease (Paget Disease, Extramammary)
12/2018 - 11/2015
3digital ulcers
09/2015 - 06/2009
3Cicatrix (Scar)
09/2013 - 05/2009

Drug/Important Bio-Agent (IBA)

59AutoantibodiesIBA
04/2022 - 06/2002
30AntibodiesIBA
07/2022 - 12/2005
22CytokinesIBA
12/2021 - 01/2003
15Proteins (Proteins, Gene)FDA Link
04/2022 - 06/2005
15Interleukin-6 (Interleukin 6)IBA
01/2021 - 06/2002
13Immunoglobulin G (IgG)IBA
02/2022 - 04/2003
12EnzymesIBA
01/2022 - 04/2003
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2017 - 01/2003
9Pharmaceutical PreparationsIBA
08/2022 - 06/2010
9Mi-2 antibodiesIBA
03/2022 - 12/2005
9NivolumabIBA
06/2020 - 06/2016
9Bleomycin (Blenoxane)FDA LinkGeneric
01/2020 - 09/2006
9Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2014 - 04/2006
8AntigensIBA
01/2022 - 10/2004
7transcriptional intermediary factor 1IBA
01/2022 - 09/2012
7Monoclonal AntibodiesIBA
05/2019 - 09/2006
7ImmunosorbentsIBA
12/2016 - 04/2003
7L-SelectinIBA
07/2014 - 04/2006
7ChemokinesIBA
11/2013 - 05/2008
7P-SelectinIBA
11/2011 - 09/2006
6Interleukin-17 (Interleukin 17)IBA
01/2022 - 06/2008
6InterferonsIBA
08/2021 - 02/2011
6AutoantigensIBA
01/2021 - 06/2002
6Immune Checkpoint InhibitorsIBA
10/2020 - 09/2016
6Interleukin-10 (Interleukin 10)IBA
09/2020 - 08/2008
6LigandsIBA
06/2017 - 03/2008
6CollagenIBA
01/2013 - 04/2003
6E-SelectinIBA
11/2011 - 09/2006
5Imiquimod (Aldara)FDA LinkGeneric
12/2022 - 01/2020
5Indicators and Reagents (Reagents)IBA
12/2021 - 06/2009
5Biomarkers (Surrogate Marker)IBA
05/2021 - 05/2011
5Antigen-Antibody Complex (Immune Complex)IBA
07/2019 - 05/2007
5Immunoglobulins (Immunoglobulin)IBA
01/2019 - 05/2009
5Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2019 - 05/2007
5anti-scl-70 autoantibodiesIBA
01/2017 - 01/2010
4nuclear matrix protein 2IBA
01/2022 - 11/2016
4UbiquitinIBA
01/2022 - 01/2013
4SteroidsIBA
04/2019 - 09/2016
4Immunoglobulin E (IgE)IBA
01/2019 - 02/2008
4Messenger RNA (mRNA)IBA
07/2014 - 09/2004
4SelectinsIBA
11/2011 - 09/2006
3HLA-DR Antigens (HLA-DR)IBA
02/2022 - 01/2022
3Ligases (Synthetase)IBA
10/2021 - 04/2013
3Prednisolone (Predate)FDA LinkGeneric
06/2021 - 01/2010
3Interferon Type IIBA
01/2021 - 06/2009
3artenimol (dihydroartemisinin)IBA
01/2021 - 09/2020
3pembrolizumabIBA
06/2020 - 01/2017
3Chemotactic FactorsIBA
04/2013 - 07/2003
3Interleukin-4 (Interleukin 4)IBA
11/2012 - 06/2008

Therapy/Procedure

15Therapeutics
08/2021 - 10/2004
5Radiotherapy
08/2021 - 01/2012
5Immunotherapy
03/2021 - 02/2017
5Drug Therapy (Chemotherapy)
12/2018 - 01/2012
3Transplantation
06/2021 - 09/2020
3Hematopoietic Stem Cell Transplantation
01/2021 - 01/2008